A survey of myeloma patient perspectives of their bisphosphonates
Thank you for taking part in this important confidential survey.
Myeloma UK has created this survey in order to understand more about the perspectives of myeloma patients regarding their bisphosphonate treatment.
We anticipate that the survey will take approximately 10 – 15 mins to complete.
The results of this survey will help us understand:
• Patient preferences for the type of bisphosphonate they receive, in particular in relation to location and setting of care, and the reasons for their preferences
• Patient involvement in the choice of bisphosphonate treatment and whether this met their expectations
• Patient needs and preferences for information about their bisphosphonate treatment and the extent to which these were met
• In general terms, patient perspectives on the treatment and care they receive
We hope that the information gathered from this survey will allow us to more accurately reflect and communicate the needs of myeloma patients to healthcare providers, funders and policy-makers.
For further information, or if you have any questions about the survey, please contact Kate Morgan on 0131 557 3332 or by emailing kate@myeloma.org.uk.
Myeloma UK has created this survey in order to understand more about the perspectives of myeloma patients regarding their bisphosphonate treatment.
We anticipate that the survey will take approximately 10 – 15 mins to complete.
The results of this survey will help us understand:
• Patient preferences for the type of bisphosphonate they receive, in particular in relation to location and setting of care, and the reasons for their preferences
• Patient involvement in the choice of bisphosphonate treatment and whether this met their expectations
• Patient needs and preferences for information about their bisphosphonate treatment and the extent to which these were met
• In general terms, patient perspectives on the treatment and care they receive
We hope that the information gathered from this survey will allow us to more accurately reflect and communicate the needs of myeloma patients to healthcare providers, funders and policy-makers.
For further information, or if you have any questions about the survey, please contact Kate Morgan on 0131 557 3332 or by emailing kate@myeloma.org.uk.